A New Approach to Vaccine Development
A Discussion of the Institute of Medicine Committee Recommendations

The current system of supplying vaccines appears to be in a state of crisis. While immunization rates among children are high, there have been periodic shortages of vaccines. In addition, there are few incentives to develop new vaccines, and a declining number of manufacturers. That has raised concerns that we would not adequately be protected against potential bioterrorist attacks or future outbreaks of serious diseases. To address this crisis a recent report by the Institute of Medicine (IOM) calls for major changes in the current system of financing vaccine purchases. The IOM recommends a government mandate that all public and private health insurance programs cover vaccines, a voucher to uninsured individuals to assure their coverage, and government subsidies for vaccines based on an estimate of their value to society.

An eleven-person panel chaired by Duke University economist Frank Sloan devised the IOM report and its recommendations. Professor Sloan and panel members Sara Rosenbaum and Mark Pauly will present the report’s findings. The report’s conclusions will be assessed by three experts in the pharmaceutical and health insurance markets: AEI economist John Calfee; Christine Grant, vice president of AventisPasteur, a major vaccine producer; and Carmella Bocchino, vice president of the association of health insurers and health plans. The IOM report: Financing Vaccines in the 21st Century: Assuring Access and Availability is available online.

Also Visit
AEIdeas Blog The American Magazine
About the Author


John E.
  • Economist John E. Calfee (1941-2011) studied the pharmaceutical industry and the Food and Drug Administration (FDA), along with the economics of tobacco, tort liability, and patents. He previously worked at the Federal Trade Commission's Bureau of Economics. He had also taught marketing and consumer behavior at the business schools of the University of Maryland at College Park and Boston University. While Mr. Calfee's writings are mostly on pharmaceutical markets and FDA regulation, his academic articles and opinion pieces covered a variety of topics, from patent law and tort liability to advertising and consumer information. His books include Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Biotechnology and the Patent System (AEI Press, 2007). Mr. Calfee wrote regularly for AEI's Health Policy Outlook series. He testified before Congress and federal agencies on various topics, including alcohol advertising; biodefense vaccine research; international drug prices; and FDA oversight of drug safety.


Robert B.


Mark V.

What's new on AEI

Making Ryan's tax plan smarter
image The teacher evaluation confronts the future
image How to reform the US immigration system
image Inversion hysteria
AEI on Facebook
Events Calendar
  • 01
  • 02
  • 03
  • 04
  • 05
Wednesday, September 03, 2014 | 9:00 a.m. – 10:30 a.m.
From anarchy to Augustus: Lessons on dealing with disorder, from Rome’s first emperor

We invite you to join us for two panel discussions on how Augustus created order from chaos 2,000 years ago, and what makes for durable domestic and international political systems in the 21st century.

Wednesday, September 03, 2014 | 12:00 p.m. – 1:30 p.m.
Multiple choice: Expanding opportunity through innovation in K–12 education

Please join us for a book launch event and panel discussion about how a marketplace of education options can help today's students succeed in tomorrow's economy. Attendees will receive a complimentary copy of the featured book.

Thursday, September 04, 2014 | 12:00 p.m. – 1:30 p.m.
How conservatives can save the safety net

Please join us for a luncheon event in which our panel will discuss what conservatives can learn from how liberals talk and think about the safety net and where free-market economics, federalism, and social responsibility intersect to lift people out of poverty.

No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.